Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > MTB123 what a sham- shame you are.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(112)
•••
Comment by MBT123on Apr 29, 2021 7:13pm
129 Views
Post# 33098582

RE:RE:MTB123 what a sham- shame you are.

RE:RE:MTB123 what a sham- shame you are. Yep real people that don't pose as stock gurus or bio tech experts, the confidence you do it in should be praised. As for insult?? The market has slapped you numerous times with this SP we don't have to as that is the ultimate insult I would think. You are a good talker maybe stick to selling used cars as I'm sure your really good at that! Your "source" weather it's in your head or from this inept management has lead you astray as well! But I'm sure all is well and these delays lack of information blah blah blah is all good moving fwd. . Another cent down better get your research paper you worked so hard on out soon and stop the bleeding the market really eats those up! As much as your NRs of fluff you write! It's hot here gotta get out catch some sun! Fat boy, inept management a part-time CEO and a used car salemsmen writing for them is all good nothing illegal! Just sucks for people underwater I know a couple. I'm good have lots just don't wanna see anyone new get suckered in.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities